Exploiting viral properties for the rational design of modern vaccines.
about
Plant-based solutions for veterinary immunotherapeutics and prophylacticsImmunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.Therapeutic antibodies directed at G protein-coupled receptorsStructural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.Rabbit hemorrhagic disease virus capsid, a versatile platform for foreign B-cell epitope display inducing protective humoral immune responses.Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine.Virus-like particle-based vaccines against hepatitis C virus infection.A bio-nanocapsule containing envelope protein domain III of Japanese encephalitis virus protects mice against lethal Japanese encephalitis virus infection.Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality.Broadly neutralizing antiviral responses induced by a single-molecule HPV vaccine based on thermostable thioredoxin-L2 multiepitope nanoparticles.Minor capsid protein L2 polytope induces broad protection against oncogenic and mucosal human papillomaviruses.Adjuvants: no longer a 'dirty little secret', but essential key players in vaccines of the future.Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide.
P2860
Q27000876-C709D416-38B7-454D-8661-9E8DBC6D208AQ33569555-E9656BB9-AC8B-4446-9104-2F7B6FF237F5Q34039347-ECE1B7D4-3B44-4F0A-97F5-FDF903E341A7Q34445135-DD6C9B2D-9D27-4E64-9332-A7883DE45AD5Q35076683-61DA4417-6111-493B-9D4D-1A1C9A94E801Q37195802-A46F6503-F3BB-4B09-9B6C-087BDA084801Q37461092-21230594-877A-4C56-A7AA-9B80515ADECEQ38081966-1B10D5C3-4903-4C63-AE26-5E656069CCA7Q39255929-FDEFA178-0602-4316-9669-B0D912F46A42Q41963402-DFFAEE88-C210-4A9D-80B0-2A73DED99DEBQ47110564-C14BB86B-679A-42A2-96C9-460C39A7A261Q47322093-E1475738-9B3E-44D2-B17E-97A9A64F24D8Q51772228-BAEA7BCC-7815-460C-B332-1D4CBA478022Q52589518-DBBFDB08-838B-4DA2-98D5-17E942B02D4A
P2860
Exploiting viral properties for the rational design of modern vaccines.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Exploiting viral properties for the rational design of modern vaccines.
@ast
Exploiting viral properties for the rational design of modern vaccines.
@en
Exploiting viral properties for the rational design of modern vaccines.
@nl
type
label
Exploiting viral properties for the rational design of modern vaccines.
@ast
Exploiting viral properties for the rational design of modern vaccines.
@en
Exploiting viral properties for the rational design of modern vaccines.
@nl
prefLabel
Exploiting viral properties for the rational design of modern vaccines.
@ast
Exploiting viral properties for the rational design of modern vaccines.
@en
Exploiting viral properties for the rational design of modern vaccines.
@nl
P2860
P356
P1476
Exploiting viral properties for the rational design of modern vaccines.
@en
P2093
Gunther Spohn
Martin F Bachmann
P2860
P356
10.1586/14760584.7.1.43
P577
2008-02-01T00:00:00Z